APLP2 Recombinant Antibody, Cy3 Conjugated
Product Specifications
Background
May play a role in the regulation of hemostasis. The soluble form may have inhibitory properties towards coagulation factors. May interact with cellular G-protein signaling pathways. May bind to the DNA 5'-GTCACATG-3' (CDEI box) . Inhibits trypsin, chymotrypsin, plasmin, factor XIA and plasma and glandular kallikrein. Modulates the Cu/Zn nitric oxide-catalyzed autodegradation of GPC1 heparan sulfate side chains in fibroblasts.
Synonyms
Aplp2; APPH; APPL2; CDEBP.
Gene ID
334
Swiss Prot
Q06481
Cellular Locus
Nucleus, Cell membrane
Host
Rabbit
Cross Reactivity
Human, Mouse, Rat
Target
APLP2
Clonality
Recombinant
Isotype
IgG
Conjugation
Cy3
Source
KLH conjugated synthetic peptide derived from human APLP2
Applications
WB, IF
Purification
Purified by Protein A.
Excitation Emission
512,550nm/570,615nm
Concentration
Lot dependent
Dilution
WB (1:300-5000), IF ()
Buffer
Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
334
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS637451-01 0.1 mL
Scl-70, Recombinant, Human, Western Blot Positive Control (Scleroderma, DNA Topoisomerase I)
Ask
View Details MBS637451-02 5x 0.1 mL
Scl-70, Recombinant, Human, Western Blot Positive Control (Scleroderma, DNA Topoisomerase I)
Ask
View Details